QA: Skye Bioscience Inc in us_pharma/2015

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001516551_2016_Skye_Bioscience_Inc.pdf

Logs

warning Missing logo subcommand.report {}

Graph

Absolute values for 0001516551, Skye Bioscience Inc

  xvar xval
0 AssetsCurrent 3,453,781
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 13,383
3 remainder_Assets 43,884
4 LiabilitiesCurrent 581,860
5 LiabilitiesNoncurrent 2,458,192
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 3,741,017
9 ResearchAndDevelopmentExpense 576,093
10 remainder_Expenses -479,894
11 remainder_Revenues 0
12 remainder_NetIncome 0
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 3,511,048
1 Liabilities 3,040,052
2 Expenses 3,837,216
3 Revenues 0
4 StockholdersEquity 470,996
5 NetIncome -3,837,216
6 ComprehensiveNetIncome -3,837,216
7 BaseVar 5,194,158
8 EconomicCapitalRatiobeforeLimitedLiability -0.858
9 EconomicCapitalRatio 1.33

Edgar->Model Mapping

Feature Distribution

Change over Time